Biologic Injectors Market
Biologic Injectors Market Size, Share & Trends Analysis Report
Biologic Injectors Market Size, Share, Statistics & Trends Analysis Report By Type (Disposable Biologic Injectors, Reusable Biologic Injectors), By Application (Hospitals, Clinics, Ambulatory Surgical Centers, Others), Based On Region, And Segment Forecasts, 2024 – 2030
Published
Report ID : BMRC 2896
Number of pages : 300
Published Date : Mar 2024
Category : Healthcare
Delivery Timeline : 48 hrs
Market Segmentation
By Type
- Disposable Biologic Injectors
- Reusable Biologic Injectors
By Application
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Key players
- Roche
- Abbott
- Schott
- Nipro
- Ompi
- Becton and Dickinson & Co.
- Bayer AG
- Pfizer, Inc.
- Bristol-Myer Squibb
- Novartis International AG
- Samedan Ltd
- E3D Elcam Drug Delivery Devices
- Zealand Pharma A/S (Valeritas, Inc.
- Ypsomed AG
- Tandem Diabetes Care, Inc.
SUMMARY
Segments
Market Segmentation
By Type
- Disposable Biologic Injectors
- Reusable Biologic Injectors
By Application
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key players
- Roche
- Abbott
- Schott
- Nipro
- Ompi
- Becton and Dickinson & Co.
- Bayer AG
- Pfizer, Inc.
- Bristol-Myer Squibb
- Novartis International AG
- Samedan Ltd
- E3D Elcam Drug Delivery Devices
- Zealand Pharma A/S (Valeritas, Inc.
- Ypsomed AG
- Tandem Diabetes Care, Inc.
